Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec 20;7(24):4368-4371.
doi: 10.3889/oamjms.2019.837. eCollection 2019 Dec 30.

A Rare Colonic Metastasis Case from Hepatocellular Carcinoma

Affiliations

A Rare Colonic Metastasis Case from Hepatocellular Carcinoma

Binh Van Pham et al. Open Access Maced J Med Sci. .

Abstract

Background: Hepatocellularcarcinoma (HCC) metastasis include intrahepatic and extrahepatic metastasis. Similar to intrahepatic metastasis, extrahepatic metastases are not unusual in cases with HCC. However, colonic metastasis is infrequent.

Case report: We describe a clinical case, he was diagnosed with HCC a year ago, treated with TACE (transarterialchemoembolisation), re-examined with abdominal pain and defecation disorder. The tests such as CT scan, colorectal endoscopy, fine needle aspiration (FNA) revealed secondary metastatic lesion of HCC in sigmoid colon. This is the first gastrointestinal (GI) tract metastatic we have encountered.

Conclusion: HCC metastases of the colon are rare, especially cases of hematogenous spread. The prognosis of these patients is often very critical. Indications for surgical removal of the lesion may be used if the general situation of patient is acceptable.

Keywords: GI metastasis; Hepatocelluar carcinoma; Sigmoid metastasis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CT scan result: A natural hypodense mass with 39 x 41 mm located in segment IV – VIII
Figure 2
Figure 2
The tumor is in submucosa, was composed of a typical polygonal cells that resemble HCC 2A) and vascular invasion 2B)
Figure 3
Figure 3
Immunohistochemicalstaiing, the tumor cells were positive for Hepar-1 3A) and Arginase-1 3B)

References

    1. Bray F, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492 PMid:30207593. - PubMed
    1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–1917. https://doi.org/10.1016/S0140-6736(03)14964-1. - PubMed
    1. Hashim D, Boffetta PP, La Vecchia C, et al. The global decrease in cancer mortality:trends and disparities. Ann Oncol. 2016;27:926–33. https://doi.org/10.1093/annonc/mdw027 PMid:26802157. - PubMed
    1. Seigel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2016;66:7–30. https://doi.org/10.3322/caac.21332 PMid:26742998. - PubMed
    1. Makariva-Rusher OV, Altekruse SF, McNeel TS. Population - attributable fractions of risk factors for hepatocellular carcinoma in the United States. Cancer. 2016;122:1757–65. https://doi.org/10.1002/cncr.29971 PMid:26998818 PMCid:PMC5548177. - PMC - PubMed

LinkOut - more resources